These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7952373)

  • 1. Plasma concentrations of midazolam during continuous subcutaneous administration in palliative care.
    Bleasel MD; Peterson GM; Dunne PF
    Palliat Med; 1994; 8(3):231-6. PubMed ID: 7952373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous midazolam infusion in palliative care.
    Bottomley DM; Hanks GW
    J Pain Symptom Manage; 1990 Aug; 5(4):259-61. PubMed ID: 2384705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ketamine, fentanyl, and midazolam infusion for uncontrolled terminal pain and agitation.
    Enck RE
    Am J Hosp Palliat Care; 2000; 17(2):76-7. PubMed ID: 11406960
    [No Abstract]   [Full Text] [Related]  

  • 4. Steady-state plasma concentrations of midazolam in critically ill infants and children.
    Hughes J; Gill AM; Mulhearn H; Powell E; Choonara I
    Ann Pharmacother; 1996 Jan; 30(1):27-30. PubMed ID: 8773161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care.
    Berger JM; Ryan A; Vadivelu N; Merriam P; Rever L; Harrison P
    Am J Hosp Palliat Care; 2000; 17(2):127-34. PubMed ID: 11406957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients.
    Miller RS; Peterson GM; Abbott F; Maddocks I; Parker D; McLean S
    Br J Clin Pharmacol; 1995 Dec; 40(6):553-6. PubMed ID: 8703661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
    Gambles M; McGlinchey T; Latten R; Dickman A; Lowe D; Ellershaw JE
    BMJ Support Palliat Care; 2011 Dec; 1(3):329-33. PubMed ID: 24653479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous Midazolam infusion for sedation of respirator patients].
    Behne M; Asskali F; Steuer A; Förster H
    Anaesthesist; 1987 May; 36(5):228-32. PubMed ID: 3631490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sedation in the terminal phase of life].
    Verhagen EH; Eliel MR; de Graeff A; Teunissen SC
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2601-3. PubMed ID: 10633803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The last few days.
    Enck RE
    Am J Hosp Palliat Care; 1992; 9(4):11-3. PubMed ID: 1457227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations and pharmacokinetics of midazolam during anaesthesia.
    Crevat-Pisano P; Dragna S; Granthil C; Coassolo P; Cano JP; Francois G
    J Pharm Pharmacol; 1986 Aug; 38(8):578-82. PubMed ID: 2876073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous midazolam for acute hemorrhage in patients with advanced cancer.
    Oneschuk D
    Can Fam Physician; 1998 Jul; 44():1461-2. PubMed ID: 9678274
    [No Abstract]   [Full Text] [Related]  

  • 13. A protocol for the acute control of agitation in palliative care: a preliminary report.
    Gonçalves F; Almeida A; Teixeira S; Pereira S; Edra N
    Am J Hosp Palliat Care; 2012 Nov; 29(7):522-4. PubMed ID: 22363035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of droperidol for the control of acutely agitated out-of-hospital patients.
    Martel M; Miner J; Fringer R; Sufka K; Miamen A; Ho J; Clinton J; Biros M
    Prehosp Emerg Care; 2005; 9(1):44-8. PubMed ID: 16036827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of midazolam used as an intravenous induction agent for patients over 80 years of age.
    Servin F; Enriquez I; Fournet M; Failler JM; Farinotti R; Desmonts JM
    Eur J Anaesthesiol; 1987 Jan; 4(1):1-7. PubMed ID: 3582373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous infusion of ketamine and midazolam for prolonged sedation in the intensive care unit].
    Kawamata M; Ujike Y; Miyabe M; Kobayashi I; Arakawa J; Namiki A; Imaizumi H; Yamaya K
    Masui; 1991 Dec; 40(12):1793-8. PubMed ID: 1770572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer.
    Ramani S; Karnad AB
    South Med J; 1996 Nov; 89(11):1101-3. PubMed ID: 8903298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Midazolam (Dormicum) in terminal anxiety and agitation. The last choice alternative in palliative care].
    Jakobsson M; Strang P
    Lakartidningen; 1999 Apr; 96(17):2079-81. PubMed ID: 10354670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of midazolam and haloperidol in cancer patients at the end of life.
    Radha Krishna LK; Poulose VJ; Goh C
    Singapore Med J; 2012 Jan; 53(1):62-6. PubMed ID: 22252186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Total intravenous anesthesia with continuous infusion of midazolam--study on plasma levels of midazolam and catecholamines].
    Nishiyama T; Odaka Y; Seto K
    Masui; 1990 Oct; 39(10):1383-7. PubMed ID: 2255046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.